Development Level

Tbio 33 | 10,625
Tchem 4 | 1,890
Tclin 3 | 602
Tdark 1 | 7,003

Collection

GPCR: IDG Consortium (Complete/Control) 1 | 26
Ion Channel: IDG Consortium (Targets) 1 | 102

IMPC Phenotype

abnormal behavior 2 | 226
hyperactivity 2 | 108
abnormal bone structure 1 | 131
abnormal coat-hair pigmentatio... 1 | 54
abnormal cornea morphology 1 | 24
abnormal epididymis morphology 1 | 31
abnormal liver morphology 1 | 5
abnormal skin morphology 1 | 23
decreased B cell number 1 | 30
decreased body length 1 | 108
decreased bone mineral content 1 | 157
decreased bone mineral density 1 | 126
decreased circulating HDL chol... 1 | 77
decreased circulating choleste... 1 | 85
decreased circulating glucose ... 1 | 121
decreased grip strength 1 | 123
decreased heart weight 1 | 44
decreased mean corpuscular hem... 1 | 19
decreased mean corpuscular vol... 1 | 50
decreased pro-B cell number 1 | 2
enlarged epididymis 1 | 27
enlarged heart 1 | 111
increased circulating sodium l... 1 | 71
increased circulating triglyce... 1 | 24
increased mean corpuscular hem... 1 | 93
increased pro-B cell number 1 | 1
increased startle reflex 1 | 38
increased vertical activity 1 | 18
jumpy 1 | 2
preweaning lethality, complete... 1 | 633
preweaning lethality, incomple... 1 | 260

Disease

ovarian cancer 24 | 8,491
medulloblastoma, large-cell 23 | 6,234
glioblastoma 22 | 5,572
osteosarcoma 22 | 7,933
oligodendroglioma 19 | 2,849
psoriasis 19 | 6,685
atypical teratoid / rhabdoid tumor 18 | 4,369
pilocytic astrocytoma 18 | 3,086
ependymoma 17 | 2,514
pediatric high grade glioma 17 | 2,712
subependymal giant cell astrocytoma 16 | 2,287
lung cancer 15 | 4,473
malignant mesothelioma 15 | 3,163
primitive neuroectodermal tumor 15 | 3,031
Breast cancer 14 | 3,098
intraductal papillary-mucinous adenoma (IPMA) 14 | 2,956
lung carcinoma 14 | 2,844
cystic fibrosis 13 | 1,670
astrocytic glioma 12 | 2,241
intraductal papillary-mucinous carcinoma (IPMC) 12 | 2,988
Carcinoma 11 | 2,147
pancreatic cancer 11 | 2,300
Pick disease 10 | 1,893
intraductal papillary-mucinous neoplasm (IPMN) 10 | 3,289
invasive ductal carcinoma 10 | 2,950
atypical teratoid/rhabdoid tumor 9 | 1,095
interstitial cystitis 9 | 2,299
lung adenocarcinoma 9 | 2,714
non-small cell lung cancer 9 | 2,798
ulcerative colitis 9 | 2,087
Down syndrome 8 | 548
Neuropathy 8 | 210
group 4 medulloblastoma 8 | 1,875
Neurodegenerative disease 7 | 383
breast carcinoma 7 | 1,614
colon cancer 7 | 1,475
pituitary cancer 7 | 1,972
sonic hedgehog group medulloblastoma 7 | 1,482
tuberculosis 7 | 1,563
Cancer 6 | 2,346
Peripheral Neuropathy 6 | 303
diabetes mellitus 6 | 1,663
group 3 medulloblastoma 6 | 2,254
Duchenne muscular dystrophy 5 | 602
cutaneous lupus erythematosus 5 | 1,056
dermatomyositis 5 | 966
gastric carcinoma 5 | 832
medulloblastoma 5 | 1,524
spina bifida 5 | 1,064
Brain disease 4 | 84
Charcot-Marie-Tooth disease 4 | 74
Epilepsy 4 | 346
IGA Glomerulonephritis 4 | 454
Leukodystrophy 4 | 30
Multiple Sclerosis 4 | 498
Prostatic Neoplasms 4 | 471
Rheumatoid Arthritis 4 | 1,170
acute myeloid leukemia 4 | 785
acute quadriplegic myopathy 4 | 1,157
adult high grade glioma 4 | 2,148
ductal carcinoma in situ 4 | 1,745
nasopharyngeal carcinoma 4 | 1,056
pancreatic carcinoma 4 | 567
pancreatic ductal adenocarcinoma liver metastasis 4 | 1,795
posterior fossa group A ependymoma 4 | 1,511
primary pancreatic ductal adenocarcinoma 4 | 1,271
progressive supranuclear palsy 4 | 674
Adenocarcinoma of lung (disorder) 3 | 48
Anemia 3 | 252
Atopic dermatitis 3 | 944
Autistic Disorder 3 | 320
Cerebrovascular disease 3 | 231
Charcot-Marie-Tooth disease type 3 3 | 6
Childhood Ataxia with Central Nervous System Hypomyelinization 3 | 5
Heart disease 3 | 279
Hypersensitivity reaction type II disease 3 | 235
Intellectual disability 3 | 573
Leukodystrophy with vanishing white matter 3 | 5
Leukoencephalopathy With Vanishing White Matter 3 | 5
Malaria 3 | 140
Mammary Neoplasms 3 | 410
OVARIOLEUKODYSTROPHY 3 | 5
Osteoporosis 3 | 259
Polyneuropathy 3 | 30
Squamous cell carcinoma 3 | 96
Status Epilepticus 3 | 85
active ulcerative colitis 3 | 477
adrenocortical carcinoma 3 | 1,427
aldosterone-producing adenoma 3 | 664
astrocytoma 3 | 1,493
gastric cancer 3 | 436
juvenile dermatomyositis 3 | 1,189
non primary Sjogren syndrome sicca 3 | 840
posterior fossa group B ependymoma 3 | 1,530
sarcoidosis 3 | 368
Adenoma 2 | 165
Amyotrophic Lateral Sclerosis 2 | 432
Liver carcinoma 2 | 217
Tinea pedis 2 | 30
Toxic encephalopathy 2 | 131

Tissue

Blood and immune system 41 | 17,994
Cardiovascular System 41 | 17,957
Digestive Tract 41 | 18,472
Endocrine System 41 | 18,511
Female tissues 41 | 18,646
Liver and Pancreas 41 | 18,135
Male tissues 41 | 17,968
Nervous System 41 | 18,560
Respiratory system 41 | 17,483
Skin and soft tissues 41 | 18,114
Urinary Tract 41 | 18,443

Target Family

Non-IDG 24 | 11,969
Enzyme 6 | 4,146
Transcription Factor 4 | 1,400
Ion Channel 3 | 341
GPCR 2 | 408
Kinase 1 | 634
Transporter 1 | 473

GO Process

myelination 41 | 41
transcription, DNA-templated 1,779 | 1,779
regulation of transcription, D... 1,170 | 1,170
signal transduction 969 | 969
positive regulation of transcr... 845 | 845
G-protein coupled receptor sig... 666 | 666
negative regulation of transcr... 620 | 620
apoptotic process 506 | 506
positive regulation of transcr... 504 | 504
negative regulation of transcr... 483 | 483
multicellular organism develop... 456 | 456
positive regulation of cell pr... 451 | 451
cell differentiation 442 | 442
negative regulation of apoptot... 440 | 440
innate immune response 410 | 410
cell adhesion 409 | 409
immune response 398 | 398
negative regulation of cell pr... 379 | 379
inflammatory response 371 | 371
viral process 367 | 367
spermatogenesis 365 | 365
cell proliferation 358 | 358
protein transport 356 | 356
intracellular signal transduct... 355 | 355
cell division 330 | 330
regulation of transcription fr... 324 | 324
protein phosphorylation 320 | 320
response to drug 297 | 297
positive regulation of apoptot... 292 | 292
nervous system development 275 | 275
transcription from RNA polymer... 272 | 272
cell surface receptor signalin... 267 | 267
protein ubiquitination 260 | 260
transport 257 | 257
cell-cell signaling 249 | 249
regulation of immune response 247 | 247
positive regulation of gene ex... 242 | 242
mitotic nuclear division 241 | 241
chemical synaptic transmission 238 | 238
MAPK cascade 237 | 237
mRNA splicing, via spliceosome 219 | 219
angiogenesis 218 | 218
small GTPase mediated signal t... 215 | 215
translation 215 | 215
rRNA processing 209 | 209
intracellular protein transpor... 205 | 205
cellular response to DNA damag... 201 | 201
cell cycle 200 | 200
proteasome-mediated ubiquitin-... 199 | 199
proteolysis 199 | 199
visual perception 198 | 198
DNA repair 196 | 196
extracellular matrix organizat... 193 | 193
regulation of apoptotic proces... 190 | 190
brain development 183 | 183
positive regulation of cell mi... 181 | 181
protein polyubiquitination 180 | 180
in utero embryonic development 178 | 178
Fc-epsilon receptor signaling ... 175 | 175
Wnt signaling pathway 175 | 175
ion transmembrane transport 174 | 174
protein homooligomerization 173 | 173
heart development 170 | 170
positive regulation of ERK1 an... 170 | 170
blood coagulation 169 | 169
cell migration 168 | 168
regulation of cell proliferati... 167 | 167
protein autophosphorylation 166 | 166
response to hypoxia 164 | 164
mRNA processing 162 | 162
protein folding 162 | 162
negative regulation of canonic... 161 | 161
response to lipopolysaccharide 161 | 161
T cell receptor signaling path... 160 | 160
defense response to virus 160 | 160
RNA splicing 158 | 158
aging 158 | 158
positive regulation of I-kappa... 158 | 158
axon guidance 157 | 157
homophilic cell adhesion via p... 155 | 155
sensory perception of smell 155 | 155
ER to Golgi vesicle-mediated t... 151 | 151
interferon-gamma-mediated sign... 150 | 150
protein ubiquitination involve... 150 | 150
transcription initiation from ... 150 | 150
ubiquitin-dependent protein ca... 149 | 149
DNA replication 144 | 144
adaptive immune response 139 | 139
cell cycle arrest 139 | 139
receptor-mediated endocytosis 139 | 139
skeletal system development 136 | 136
regulation of cell shape 135 | 135
regulation of small GTPase med... 134 | 134
G2-M transition of mitotic cel... 133 | 133
oxidation-reduction process 133 | 133
positive regulation of cytosol... 133 | 133
protein stabilization 133 | 133
sensory perception of sound 132 | 132
positive regulation of NF-kapp... 131 | 131
type I interferon signaling pa... 130 | 130
endocytosis 129 | 129

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Receptor tyrosine-protein kinase erbB-2 ERBB2 Tclin Kinase -4.25806 19000.3 3336
Protein quaking QKI Tbio Non-IDG -1.81649 63.7 254
Desert hedgehog protein DHH Tbio Non-IDG -2.22195 152.9 260
Junctional adhesion molecule C JAM3 Tbio Non-IDG -1.89346 55.4 183
Neurofascin NFASC Tbio Non-IDG -2.04016 102.8 150
Sodium channel protein type 2 subunit alpha SCN2A Tclin Ion Channel -3.09876 1152.7 107
NGFI-A-binding protein 2 NAB2 Tbio Non-IDG -1.87835 68.0 235
Translation initiation factor eIF-2B subunit epsilon EIF2B5 Tbio Non-IDG -1.89476 79.4 103
Tetraspanin-2 TSPAN2 Tbio Non-IDG -1.21387 14.4 176
Sodium/calcium exchanger 3 SLC8A3 Tbio Transporter -1.84077 53.3 118